PAR 5.88% 24.0¢ paradigm biopharmaceuticals limited..

FA bagger potential, page-52

  1. 91 Posts.
    lightbulb Created with Sketch. 20
    I'm still struggling to accept the fiftyonecapital report's assumption of 90% success on the phase 2 trial. That's a fairly bold statement.

    The phase 1 trials should have been somewhat expected as similar studies have been done before. Also, i didn't see any mention about any results so far relative to a placebo group.
    In saying that ,I haven't spent a huge amount of time on this so i hope i'm wrong as we can continue to ride the wave. DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.015(5.88%)
Mkt cap ! $84.05M
Open High Low Value Volume
25.5¢ 26.5¢ 24.0¢ $167.2K 671.5K

Buyers (Bids)

No. Vol. Price($)
3 108741 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 9700 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.